1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Breast cancer

Tucatinib with trastuzumab and pertuzumab for maintenance treatment of HER2-positive unresectable advanced breast cancer after induction chemotherapy [ID6402]

Awaiting development [GID-TA11487] Expected publication date: TBC

  • Project information
  • Project documents

NIHRIO BN: 34113-Tucatinib-Trastuzumab-Pertuzumab-for-Breast-Cancer-V1.0-NOV2023-NON-CONF.pdf (nihr.ac.uk)